# Sheng‐Kai Liang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sheng-kai-liang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 830 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 15 |
| i10-index | 17 |
| Last Known Institution | National Taiwan University |
| OpenAlex ID | https://openalex.org/A5004095357 |
| ORCID iD | 0000-0003-3486-2293 |
| Works | 54 |

## Researcher papers

- [Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer](https://scholariq.org/papers/exploring-volatile-organic-compounds-in-breath-for-high-accuracy-prediction-of/)
- [Enhanced mixing in a simulated combustor using synthetic jet actuators](https://scholariq.org/papers/enhanced-mixing-in-a-simulated-combustor-using-synthetic-jet-actuators/)
- [Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy](https://scholariq.org/papers/evaluating-pleural-ada-ada2-ifn-and-igra-for-diagnosing-tuberculous-pleurisy/)
- [Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma](https://scholariq.org/papers/real-world-experience-of-afatinib-as-a-first-line-therapy-for-advanced-i-egfr-i/)
- [FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis](https://scholariq.org/papers/foxm1-is-required-for-small-cell-lung-cancer-tumorigenesis-and-associated-with/)
- [Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells](https://scholariq.org/papers/vorinostat-enhances-the-cisplatin-mediated-anticancer-effects-in-small-cell-lung/)
- [Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model](https://scholariq.org/papers/predicting-lung-cancer-occurrence-in-never-smoking-females-in-asia-tnsf-sq-a/)
- [Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations](https://scholariq.org/papers/afatinib-is-effective-in-the-treatment-of-lung-adenocarcinoma-with-uncommon-egfr/)
- [Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000–2014](https://scholariq.org/papers/clinical-characteristics-of-bacteraemia-caused-by-lactobacillus-spp-and/)
- [LncPVT1 promotes cartilage degradation in diabetic OA mice by downregulating miR-146a and activating TGF-β/SMAD4 signaling](https://scholariq.org/papers/lncpvt1-promotes-cartilage-degradation-in-diabetic-oa-mice-by-downregulating-mir/)
- [Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients with<i>EGFR</i>-mutated non-small cell lung cancer treated with afatinib](https://scholariq.org/papers/next-generation-sequencing-reveals-genetic-heterogeneity-and-resistance/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [FOXO transcription factor regulation](https://scholariq.org/topics/foxo-transcription-factor-regulation/)
- [Infectious Diseases and Mycology](https://scholariq.org/topics/infectious-diseases-and-mycology/)

## Researcher university

- [National Taiwan University](https://scholariq.org/institutions/national-taiwan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.